PCP AUXILLARY DIRECTIVES Flashcards

1
Q

CPAP indications

A
  • severe respiratory distress AND
  • signs and or symptoms of acute pulmonary edema or COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CPAP contraindications

A
  • asthma exacerbation
  • suspected pneumothorax
  • unprotected or unstable airway
  • major trauma or burns to the head or torso
  • tracheostomy
  • inability to sit upright
  • unable to cooperate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

CPAP treatment

A
  • initial 5cm
  • titration 2.5cm
  • interval 5 mins
  • max 15cm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

cardiogenic shock indications

A
  • STEMI positive 12 lead ECG AND
  • cariogenic shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

cariogenic shock conditions 0.9% NaCl FB

A

> 18
hypotension
chest auscultation is clear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

cariogenic shock contraindications 0.9% NaCl FB

A
  • fluid overload
  • SBP >90mmHg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

cariogenic shock conditions 0.9% NaCl FB

A

iv
- 10ml/kg
- reassess every 250 mls
- max 1000mls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

IV fluid therapy indications

A

actual or potential need for IV medication or fluid therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Iv fluid therapy conditions for iv cannulation

A

> 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Iv fluid therapy conditions for NaCl FB

A

> 2 years
hypotensive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Iv fluid therapy contraindications iv cannulation

A

Suspected fracture proximal to the access site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Iv fluid therapy contraindication NaCl FB

A

fluid overload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Iv fluid therapy treatment NaCl >2 years - <12 years maintenance infusion

A

IV
-15ml/hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Iv fluid therapy treatment NaCl >12 years maintenance infusion

A

IV
- 30-60 ml/hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Iv fluid therapy mandatory patch point

A

Patch to BHP for authorization to administer 0.9% NaCl fluid bolus to hypotensive patients ≥2 years to <12 years with suspected Diabetic Ketoacidosis (DKA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Iv fluid therapy treatment NaCl >2 years - <12 years FB

A

IV
20ml/kg
reassess every 100ml
max 2000ml

17
Q

Iv fluid therapy treatment NaCl >12 years FB

A

IV
20ml/kg
reassess every 250ml
max 2000ml

17
Q

seizure considerations for treat and discharge

A
  • the patient is ≥18 AND <65 years old;
  • patient must have a history of epilepsy;
  • the patient is taking their anticonvulsant medication as prescribed;
  • the patient must have only had a single seizure episode in the past 24 hours;
  • the seizure pattern and duration must be similar to past seizures;
  • the patient has returned to their normal level of consciousness;
  • a complete set of vital signs including temperature are within expected normal
    ranges;
    AND
  • the seizure must not be related to hypoglycemia, alcohol or substance abuse or withdrawal;
  • the patient must not have received midazolam by paramedics;
  • the patient did not injure themselves during seizure activity;
  • the patient must not have a fever, preceding illness or recently started a new
    medication, and;
  • the patient is not pregnant.
18
Q

seizure in addition requirements

A
  • a responsible adult agrees to remain with the patient for the next 4 hours;
  • all of the patient or substitute decision makers questions were answered
    and a care plan was developed;
  • the patient or substitute decision maker has been advised to follow up with their primary health care team or provider;
  • clear instructions to call 911 were provided should symptoms redevelop;
  • patient or substitute decision maker has the ability to access 911
    should symptoms redevelop, and
  • patient or substitute decision maker consents to the discharge.